BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26516143)

  • 1. Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients.
    Wen L; Li J; Guo H; Liu X; Zheng S; Zhang D; Zhu W; Qu J; Guo L; Du D; Jin X; Zhang Y; Gao Y; Shen J; Ge H; Tang F; Huang Y; Peng J
    Cell Res; 2015 Nov; 25(11):1250-64. PubMed ID: 26516143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing.
    Li J; Zhou X; Liu X; Ren J; Wang J; Wang W; Zheng Y; Shi X; Sun T; Li Z; Kang A; Tang F; Wen L; Fu W
    Clin Chem; 2019 Jul; 65(7):916-926. PubMed ID: 31010820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.
    Arai E; Ushijima S; Gotoh M; Ojima H; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
    Int J Cancer; 2009 Dec; 125(12):2854-62. PubMed ID: 19569176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.
    Anwar SL; Albat C; Krech T; Hasemeier B; Schipper E; Schweitzer N; Vogel A; Kreipe H; Lehmann U
    Int J Cancer; 2013 Aug; 133(3):660-70. PubMed ID: 23364900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients.
    Ren J; Lu P; Zhou X; Liao Y; Liu X; Li J; Wang W; Wang J; Wen L; Fu W; Tang F
    Clin Chem; 2022 Feb; 68(2):354-364. PubMed ID: 34791072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC.
    Qiu G; Fang J; He Y
    Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma.
    Moribe T; Iizuka N; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Cancer; 2009 Jul; 125(2):388-97. PubMed ID: 19384946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma.
    Ammerpohl O; Pratschke J; Schafmayer C; Haake A; Faber W; von Kampen O; Brosch M; Sipos B; von Schönfels W; Balschun K; Röcken C; Arlt A; Schniewind B; Grauholm J; Kalthoff H; Neuhaus P; Stickel F; Schreiber S; Becker T; Siebert R; Hampe J
    Int J Cancer; 2012 Mar; 130(6):1319-28. PubMed ID: 21500188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
    Wong IH; Lo YM; Zhang J; Liew CT; Ng MH; Wong N; Lai PB; Lau WY; Hjelm NM; Johnson PJ
    Cancer Res; 1999 Jan; 59(1):71-3. PubMed ID: 9892188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients.
    Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ
    Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma.
    Huang G; Krocker JD; Kirk JL; Merwat SN; Ju H; Soloway RD; Wieck LR; Li A; Okorodudu AO; Petersen JR; Abdulla NE; Duchini A; Cicalese L; Rastellini C; Hu PC; Dong J
    Clin Chem Lab Med; 2014 Jun; 52(6):899-909. PubMed ID: 24406287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.
    Shen J; Wang S; Zhang YJ; Wu HC; Kibriya MG; Jasmine F; Ahsan H; Wu DP; Siegel AB; Remotti H; Santella RM
    Epigenetics; 2013 Jan; 8(1):34-43. PubMed ID: 23208076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage.
    Nagashio R; Arai E; Ojima H; Kosuge T; Kondo Y; Kanai Y
    Int J Cancer; 2011 Sep; 129(5):1170-9. PubMed ID: 21400512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma.
    Kondo Y; Kanai Y; Sakamoto M; Mizokami M; Ueda R; Hirohashi S
    Hepatology; 2000 Nov; 32(5):970-9. PubMed ID: 11050047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network.
    Deng Z; Ji Y; Han B; Tan Z; Ren Y; Gao J; Chen N; Ma C; Zhang Y; Yao Y; Lu H; Huang H; Xu M; Chen L; Zheng L; Gu J; Xiong D; Zhao J; Gu J; Chen Z; Wang K
    Genome Med; 2023 Nov; 15(1):93. PubMed ID: 37936230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.